EUVIMEDEUVIMED entdecken
Open Access

In Vivo Pharmacodynamic Profile of EVER206, a Novel Polymyxin Antimicrobial, against Gram-Negative Bacteria in the Murine Thigh Infection Model

Christian M Gill iD, David P Nicolau iD

Antimicrobial Agents and Chemotherapy · 2023

DOI: 10.1128/aac.01738-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Christian M Gill und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Anti-Infective Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Everest Medicines.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objective was to determine the magnitude of the EVER206 free-plasma area under the concentration time curve ( f AUC)/MIC target associated with bacteriostasis and 1-log 10 kill against clinically relevant Gram-negative bacteria in the murine thigh model. Twenty-seven clinical isolates ( Pseudomonas aeruginosa , n = 10; Escherichia coli , n = 9; Klebsiella pneumoniae , n = 5; Enterobacter cloacae , n = 2; and Klebsiella aerogenes , n = 1) were tested.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsAnti-Infective AgentsMiceAnimalsThighPolymyxinsEscherichia coliKlebsiella pneumoniaeBacteriaMicrobial Sensitivity Tests

Stichwörter der Autor:innen

EVER206Gram-negative bacteriaSPR206in vivopharmacodynamicspharmacokinetics

Substanzen

Anti-Bacterial AgentsPolymyxinsAnti-Infective Agents

Autor:innen und Institutionen

  • Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA.
  • Division of Infectious Diseases, Hartford Hospital, Hartford, Connecticut, USA.

ORCID-Profile: Christian M Gill, David P Nicolau

Förderung

  • Everest Medicines

Zitieren

APA

Gill, C. M., & Nicolau, D. P. (2023). In Vivo Pharmacodynamic Profile of EVER206, a Novel Polymyxin Antimicrobial, against Gram-Negative Bacteria in the Murine Thigh Infection Model. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01738-22

Vancouver

Gill CM, Nicolau DP. In Vivo Pharmacodynamic Profile of EVER206, a Novel Polymyxin Antimicrobial, against Gram-Negative Bacteria in the Murine Thigh Infection Model. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01738-22

BibTeX
@article{Gill2023,
  author = {Gill, Christian M and Nicolau, David P},
  title = {In Vivo Pharmacodynamic Profile of EVER206, a Novel Polymyxin Antimicrobial, against Gram-Negative Bacteria in the Murine Thigh Infection Model},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  doi = {10.1128/aac.01738-22}
}
Kostenlos starten →